BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
2727008
Number of visits today
1495
Number of downloads
1998389
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Shwe TH, Pothacharoen P, Phitak T, Wudtiwai B, Kongtawelert P. Atorvastatin Attenuates Programmed Death Ligand-1 (PD-L1) Induction in Human Hepatocellular Carcinoma Cells. Int J Mol Sci 2021;22:8755. [PMID: 34445462 DOI: 10.3390/ijms22168755] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Choi B, Choi H, Kim H, Choi A, Kwon S, Mouli SK, Lewandowski RJ, Kim D. Z-domain protein nano-bio interfaced MRI visible anti-program death ligand-1 nanoconjugates for enhanced local immune checkpoint inhibitor immunotherapy. Nano Today 2022;45:101552. [DOI: 10.1016/j.nantod.2022.101552] [Reference Citation Analysis]
2 Escobedo-calvario A, Chávez-rodríguez L, Simoni-nieves A, Souza-arroyo V, Miranda-labra RU, Gomez-quiroz LE, Gutiérrez-ruíz MC. Tumor immune microenvironment modulation by cholesterol in hepatocellular carcinoma. Explor Dig Dis 2022. [DOI: 10.37349/edd.2022.00003] [Reference Citation Analysis]
3 Zhang L, Wang H, Tian J, Sui L, Chen X, Niu B. Concomitant Statins and the Survival of Patients with Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Meta-Analysis. International Journal of Clinical Practice 2022;2022:1-10. [DOI: 10.1155/2022/3429462] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345